While antibiotics work on bacteria rather than viruses, the current coronoavirus and its related covid-19 disease has roiled societies with the speed of transmission from animals to humans and lack of medical tools to prevent or treat it. Farms use of antibiotics has been seen as a leading cause of antibiotic resistance and so finding alternatives to mass-production of meat and dairy has been welcomed by campaigners, such as Jeremy Coller*.
South Korea’s Mirae Asset Global Investments led Impossible Foods’s latest series F round, with other investors in this round including VC firm Khosla Ventures, family office Horizons Ventures and sovereign wealth fund Temasek, although no mention of GV, the Alphabet corporate venturing subsidiary formerly known as Google Ventures that had backed a $75m round in 2014, revealed when Impossible emerged out of stealth.
*Disclosure: a shareholder in Mawsonia, publisher of Global Corporate Venturing
